Community post

David Lebeaux (Université de Paris) and colleagues published the first demonstration of phage therapy in a lung-transplanted cystic fibrosis patient infected with pandrug resistant A. xylosoxidans. They successfully carried out two rounds of therapy on a 12-year-old patient with complex airway colonization of eight distinct types of phage-resistant and -susceptible strains. The outcome: improved respiratory conditions, low airway colonization, and no further recolonization after two years of therapy.